A platform for collecting cancer tissue samples
Official title: PINCER (A Platform Study for solId orgaN CancERs); an Agile Regional Platform Study to Deliver High Quality Translational Research
Run by University of Liverpool · NCT05650125 · Data updated 2026-11-12
This study is trying to gather cancer tissue samples from patients having surgery or biopsies to help with research on solid organ cancers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 100 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University of Liverpool Academic / other |
| Locations | 1 site (Liverpool) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | August 1, 2025 |
| Trial ID | NCT05650125 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults undergoing biopsy or surgical resection for any solid organ cancer.
✕Probably not a fit
Patients who refuse or are unable to consent, as well as pediatric patients, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a comprehensive platform for the collection of biosamples from patients undergoing surgery or biopsy for solid organ cancers. It will facilitate the efficient gathering of both historical and fresh tissue samples, along with matched clinical and radiological data, to support various translational research projects. Researchers can propose specific sub-studies that will be reviewed and approved by the PINCER steering committee, ensuring alignment with the overarching protocol. The focus is on maximizing access to high-quality biosamples for cancer research without generating a biobank.
Why it matters
Potential benefit: If successful, this study could significantly enhance the availability of high-quality biosamples for cancer research, leading to better understanding and treatment options for patients.
How similar studies have gone: Other studies utilizing similar biosampling platforms have shown success in enhancing cancer research, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biopsy or surgical resection as standard of care Exclusion Criteria: * Refusal or inability to consent, paediatric patients
Where it's running
-
University of Liverpool
Liverpool, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating how ectopic fat affects heart attack risk in people living with HIV
This study looks at how extra fat around organs affects the risk of heart attacks in people living with HIV to help improve their heart health.
-
Assessing soleus muscle strength in patients with ACL tears
This study is testing the strength of a muscle in the calf of people with ACL tears to see how it compares to their uninjured leg and to healthy volunteers.
-
Optimizing doravirine dosing for pregnant women with HIV
This study is testing if a new HIV medication called doravirine is safe and effective for pregnant women during their second trimester to help improve treatment options for them.
-
Using a robotic exoskeleton for upper limb rehabilitation in spinal cord injury patients
This study is testing a robotic device to help people with spinal cord injuries improve their arm movement and independence during rehabilitation.
-
Exploring arginine supplementation for immune response in postoperative infants
This study is testing if giving arginine supplements can help improve the immune response in infants who have had major bowel surgery or have a serious gut condition.
-
AGILE: an early-phase platform testing treatments for COVID-19
This project tests several experimental antiviral and immune therapies to see if they are safe and work for adults with confirmed COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.